Chinese stocks fell Thursday, tracking Wall Street losses after the U.S. Federal Reserve raised rates under new Chair Kevin Warsh.
The Shanghai Composite Index, the main gauge of Chinese stocks, closed 0.4% lower at 3,875.60. The Shenzhen Component Index dipped 0.3% to 13,409.91.
The Fed lifted rates by 25 basis points-the first hike since 2023-and signaled more increases to curb oil-driven inflation, sparking a U.S. sell-off that dented risk appetite in China.
In company news, ShenGu Group (SHA:601091) shares closed at 20.80 yuan per share on their first day of trading on Shanghai's Main Board. This marked a 374% jump from the equipment manufacturer's initial public offering price of 4.39 yuan per share.
Elsewhere, Beijing Sun-Novo Pharmaceutical Research (SHA:688621) received approval from China's National Medical Products Administration to begin clinical trials for its BTP0427 compound sustained-release capsules.